Takeda Pharmaceutical Files 6-K Report
Ticker: TKPHF · Form: 6-K · Filed: Apr 14, 2025 · CIK: 1395064
| Field | Detail |
|---|---|
| Company | Takeda Pharmaceutical Co Ltd (TKPHF) |
| Form Type | 6-K |
| Filed Date | Apr 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: foreign-private-issuer, sec-filing, routine-report
TL;DR
Takeda filed its monthly 6-K, confirming its foreign private issuer status and Tokyo HQ.
AI Summary
Takeda Pharmaceutical Company Limited filed a Form 6-K on April 14, 2025, reporting as a foreign private issuer. The filing is for the month of April 2025 and indicates Takeda files annual reports under Form 20-F. The company's principal executive offices are located in Tokyo, Japan.
Why It Matters
This filing provides routine updates for Takeda Pharmaceutical as a foreign private issuer, informing investors about its reporting status and location.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain new financial or operational information.
Key Players & Entities
- Takeda Pharmaceutical Company Limited (company) — Registrant
- Tokyo (location) — Principal executive offices location
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934, for the submission of information which the registrant is required to publish, announce or otherwise make public in or outside the United States.
What is Takeda Pharmaceutical's filing status with the SEC?
Takeda Pharmaceutical Company Limited is a foreign private issuer and files annual reports under Form 20-F.
Where are Takeda Pharmaceutical's principal executive offices located?
Takeda Pharmaceutical's principal executive offices are located at 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, 103-8668, Japan.
What is the SEC file number for Takeda Pharmaceutical?
Takeda Pharmaceutical's SEC file number is 001-38757.
What period does this Form 6-K cover?
This Form 6-K is for the month of April 2025.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 14, 2025 regarding TAKEDA PHARMACEUTICAL CO LTD (TKPHF).